These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6762195)

  • 1. Immunotherapy maintenance in acute non-lymphocytic leukaemia.
    Paton CM; Bishop JF; Mathews JD; Whiteside MG
    Aust N Z J Med; 1982 Dec; 12(6):583-9. PubMed ID: 6762195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized comparison of maintenance treatment with androgens, immunotherapy, and chemotherapy in adult acute myelogenous leukemia. A Leukemia-Lymphoma Group Trial of the EORTC.
    Hayat M; Jehn U; Willemze R; Haanen C; Zittoun R; Monconduit M; Lowenberg B; Stryckmans P; Peetermans M; De Cataldo F
    Cancer; 1986 Aug; 58(3):617-23. PubMed ID: 3524789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acute myelogenous leukemia: influence of three induction regimens and maintenance with chemotherapy or BCG immunotherapy.
    Omura GA; Vogler WR; Lefante J; Silberman H; Knospe W; Gordon D; Jarrell R
    Cancer; 1982 Apr; 49(8):1530-6. PubMed ID: 7039813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non-lymphoblastic acute leukaemia: maintenance therapy by trial of a combination of chemo- and immunotherapy (author's transl)].
    Sébahoun G; Gastaut JA; Imbert-Xeridat C; Favre R; Carcassonne Y
    Nouv Presse Med; 1979 Feb; 8(9):663-5. PubMed ID: 377219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission maintenance for acute nonlymphocytic leukemia: cytosine arabinoside plus 6-thioguanine versus a sequence of drug regimens.
    Presant CA; Berger NA; Klahr C; Phillips GL
    Cancer; 1980 Jul; 46(1):22-8. PubMed ID: 6930320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy alone vs no maintenance treatment in acute myelogenous leukaemia.
    Zuhrie SR; Harris R; Freeman CB; MacIver JE; Geary CG; Delamore IW; Tooth JA
    Br J Cancer; 1980 Mar; 41(3):372-7. PubMed ID: 6992827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunotherapy of acute myelogenous leukaemia using intravenous BCG.
    Whittaker JA; Slater AJ
    Br J Haematol; 1977 Feb; 35(2):263-73. PubMed ID: 322696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active immunotherapy in acute myelogenous leukaemia and the induction of second and subsequent remissions.
    Harris R; Zuhrie SR; Freeman CB; Taylor GM; MacIver JE; Geary CG; Delamore IW; Hull PJ; Tooth JA
    Br J Cancer; 1978 Feb; 37(2):282-8. PubMed ID: 272913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of adult acute myelogenous leukaemia.
    Crowther D; Powles RL; Bateman CJ; Beard ME; Gauci CL; Wrigley PF; Malpas JS; Fairley GH; Scott RB
    Br Med J; 1973 Jan; 1(5846):131-7. PubMed ID: 4513355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant specific immunotherapy in maintenance treatment of adult acute non-lymphocytic leukemia.
    Rühl H; Fülle HH; Koeppen KM; Schwerdtfeger R
    Klin Wochenschr; 1981 Nov; 59(21):1189-93. PubMed ID: 6947118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of acute myelogenous leukemia in patients over the age of 50: a randomized Southeastern Cancer Study Group trial.
    Stein RS; Vogler WR; Winton EF; Cohen HJ; Raney MR; Bartolucci A
    Leuk Res; 1990; 14(10):895-903. PubMed ID: 2259226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged remission maintenance in acute myeloid leukaemia.
    Spiers AS; Goldman JM; Catovsky D; Costello C; Galton DA; Pitcher CS
    Br Med J; 1977 Aug; 2(6086):544-7. PubMed ID: 268229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.
    Arlin Z; Case DC; Moore J; Wiernik P; Feldman E; Saletan S; Desai P; Sia L; Cartwright K
    Leukemia; 1990 Mar; 4(3):177-83. PubMed ID: 2179638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of refractory adult acute lymphocytic leukaemia and acute undifferentiated leukaemia with an anthracycline antibiotic and cytosine arabinoside.
    Early AP; Preisler HD; Gottlieb AJ; Lanchant NA
    Br J Haematol; 1981 Jul; 48(3):369-75. PubMed ID: 7259987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose intensification in acute myeloid leukaemia: greater effectiveness at lower cost. Principal report of the Medical Research Council's AML9 study. MRC Leukaemia in Adults Working Party.
    Rees JK; Gray RG; Wheatley K
    Br J Haematol; 1996 Jul; 94(1):89-98. PubMed ID: 8757514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult acute leukaemia.
    Atkinson K; Wells DG; Clink HM; Kay HE; Powles R; McElwain TJ
    Br J Cancer; 1974 Sep; 30(3):272-8. PubMed ID: 4141625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized study of individualized induction therapy with or without vincristine, and of maintenance-intensification therapy between 4 or 12 courses in adult acute myeloid leukemia. AML-87 Study of the Japan Adult Leukemia Study Group.
    Ohno R; Kobayashi T; Tanimoto M; Hiraoka A; Imai K; Asou N; Tomonaga M; Tsubaki K; Takahashi I; Kodera Y
    Cancer; 1993 Jun; 71(12):3888-95. PubMed ID: 8508355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy for adult acute nonlymphocytic leukemia with daunorubicin and cytosine arabinoside.
    Cassileth PA; Katz ME
    Cancer Treat Rep; 1977 Nov; 61(8):1441-5. PubMed ID: 922749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Breakthrough in hematology?].
    Reizenstein P
    Lakartidningen; 1974 Aug; 71(32):2925-8. PubMed ID: 4605540
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of immunotherapy on survival of patients with acute myelogenous leukaemia after relapse.
    Powles R; Toy JL
    Haematologia (Budap); 1976; 10(1):5-9. PubMed ID: 1070466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.